European equities traded in the US as American depositary receipts opened the week higher late Monday morning, rising 0.77% to 1,603.65 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies Cellectis (CLLS) and Genfit (GNFT), which climbed 12.2% and 7.2% respectively. They were followed by 3D printer company Materialise (MTLS) and lender Banco Bilbao Vizcaya Argentaria (BBVA), which advanced 4.8% and 2.4% respectively.

The decliners from continental Europe were led by petroleum refiner Equinor (EQNR) and telecommunications operator Telefonica (TEF), which fell 2.2% and 1.4% respectively. They were followed by consumer goods giant Unilever (UL) and telecommunications company Ericsson (ERIC), which were down 1% and 0.8% respectively.

From the UK and Ireland, the gainers were led by alcoholic beverage company Diageo (DEO) and biotech firm Autolus Therapeutics (AUTL), which rose 4.9% and 2.2% respectively. They were followed by pharmaceutical company AstraZeneca (AZN) and biopharmaceutical company Amarin (AMRN), which were up 1.6% and 0.9% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics (AKTX) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which dropped 6% and 4.4% respectively. They were followed by software firm Endava (DAVA) and pharmaceutical company Silence Therapeutics (SLN), which lost 3% and 1.2% respectively.